This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Reflux Oesophagitis
and you are a man who is
between 18 and 45
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The objective of the study was to assess whether the tolerance to the effect of YF476 on gastric pH observed with repeated doses in a previous study in healthy volunteers can be avoided by using smaller doses of YF476.

Provided treatments

  • Drug: YF476
Tris trial is registered with FDA with number: NCT01597674. The sponsor of the trial is Trio Medicines Ltd. and it is looking for 49 volunteers for the current phase.
Official trial title:
A Double-blind, Placebo-controlled, Parallel-group Study of the Effect of 5, 10 and 25 mg Daily of YF476 for 14 Days on 24-hour Ambulatory Gastric pH and Plasma Gastrin Concentrations in Healthy Volunteers